Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACSS2 | Q9NR19 | 1/20 | 0.37 |
| ▸ | PARP1 | P09874 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | ACR | P10323 | 1/20 | 0.32 |
| ▸ | GSK3B | P49841 | 3/20 | 0.31 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.31 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.30 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6425771 | 0.88 | ABL1 (0.35) | MEN1HPGDMAPK1KMT2AGSK3B | |
| SCHEMBL6429412 | 0.86 | ACSS2 (0.39) | ACSS2KDM4EMEN1ALDH1A1HPGD | |
| SCHEMBL6426112 | 0.86 | ACSS2 (0.39) | ACSS2KDM4EMEN1ALDH1A1HPGD | |
| SCHEMBL4136676 | 0.85 | NPC1 (0.33) | PARP1KDM4EALDH1A1HPGDMAPK1 | |
| SCHEMBL4136670 | 0.85 | NPC1 (0.33) | PARP1KDM4EALDH1A1HPGDMAPK1 | |
| SCHEMBL5031165 | 0.85 | ACSS2 (0.36) | ACSS2KDM4EMEN1ALDH1A1HPGD | |
| SCHEMBL6427764 | 0.85 | CNR1 (0.33) | SCN9A | |
| SCHEMBL4153231 | 0.84 | P4HTM (0.36) | KDM4EGSK3B | |
| SCHEMBL4153221 | 0.84 | P4HTM (0.36) | KDM4EGSK3B | |
| SCHEMBL4153196 | 0.83 | SLC6A12 (0.37) | PARP1KDM4EALDH1A1GSK3BDYRK1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050261339-A1 | Pyrazole compound and medicinal composition containing the same | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2005-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261339-A1 | Pyrazole compound and medicinal composition containing the same | CNKSR1, NR3C2, CSNK2B | ACSS2 3439/4885PARP1 3155/4885KDM4E 2795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.